SIRT1 and diabetic kidney disease: Both podocyte‐specific Sirt1 overexpression and Sirt1 agonist treatment could attenuate diabetes‐induced podocyte apoptosis and effectively alleviate the progression of diabetic kidney disease in diabetic mice.12